Deparment of Vascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
J Vasc Surg. 2010 Apr;51(4):951-61; discussion 961. doi: 10.1016/j.jvs.2009.11.075.
Transcription factor signal transducer and activator of transcription (STAT) 1 has been linked to a variety of pathologic states involved with matrix remodeling, but its role in aortic pathology has not been previously described. The current study hypothesized that STAT1 regulates aneurysmal degeneration and its role was evaluated in human abdominal aortic aneurysm (AAA) and in a mouse model of aortic dissection.
Apolipoprotein E knockout mice (ApoE-/-) or ApoE/STAT1 double knockout mice (ApoE/STAT1-/-) were infused with 1000 ng/kg/min of angiotensin II. Systolic blood pressure (SBP) was measured in the rodent tail. At sacrifice, aortic diameters and extent of aneurysm formation were measured by digital microscopy. STAT1 and phosphorylated-STAT1 protein levels were assessed in ApoE-/- mice at 0, 7, 14, and 28 days (n = 8/time point) by enzyme-linked immunosorbent assay. Histology was performed using hematoxylin and eosin (H&E) and Movat stains. Statistical analyses included chi(2) test, t test, and analysis of variance.
STAT1 messenger RNA and total protein were greater in human AAA vs non-AAA controls. In addition, aneurysms occurred in 8%, 50%, and 80% of ApoE-/- mice at 7, 14, and 28 days, respectively. Total STAT1 levels were not altered during the course of angiotensin II infusion. Phosphorylated STAT1 levels peaked at 7 days with a 1.4-fold increase over baseline (P < .05). Aneurysms occurred in 0%, 100%, and 100% of ApoE/STAT1-/- mice at 3, 5, and 28 days. In mice infused with angiotensin II for >3 days, aortic rupture occurred more frequently in ApoE/STAT-/- mice (53% vs 19%, P < .05) and at earlier time points (4.0 +/- 0.5 vs 9.2 +/- 0.77 days, P < .05) vs ApoE-/- mice. SBP did not differ between the groups during angiotensin II infusion. By 28 days, aneurysms were larger in ApoE/STAT1-/- mice compared with ApoE-/- mice (2.7 +/- 0.4 vs 1.9 +/- 0.1 mm, P < .05) and were more extensive. H&E and Movat stain did not reveal differences in aortic wall structural content at baseline between ApoE-/- and ApoE/STAT1-/- mice. Both groups demonstrated equal disorganization in the aneurysmal state.
Phosphorylated STAT1 is elevated during aneurysmal degeneration. Its loss is associated with a higher rate of acute aortic rupture and more extensive aneurysms in a mouse model of aortic dissection. Further investigation is necessary to determine whether these observations are secondary to an underlying aortic wall abnormality or alterations in vessel wall matrix remodeling.
转录因子信号转导和转录激活因子(STAT)1 与多种涉及基质重塑的病理状态有关,但它在主动脉病理学中的作用尚未被描述。本研究假设 STAT1 调节动脉瘤变性,并在人腹主动脉瘤(AAA)和主动脉夹层的小鼠模型中评估了其作用。
载脂蛋白 E 基因敲除小鼠(ApoE-/-)或载脂蛋白 E/STAT1 双基因敲除小鼠(ApoE/STAT1-/-)经血管紧张素 II 输注 1000ng/kg/min。通过鼠尾测量收缩压(SBP)。在处死时,通过数字显微镜测量主动脉直径和动脉瘤形成程度。通过酶联免疫吸附试验(ELISA)在 ApoE-/- 小鼠中在 0、7、14 和 28 天时评估 STAT1 和磷酸化-STAT1 蛋白水平(n=8/时间点)。使用苏木精和伊红(H&E)和 Movat 染色进行组织学检查。统计分析包括卡方检验、t 检验和方差分析。
与非 AAA 对照组相比,人类 AAA 中 STAT1 信使 RNA 和总蛋白水平更高。此外,ApoE-/- 小鼠分别在 7、14 和 28 天时发生动脉瘤的比例为 8%、50%和 80%。在血管紧张素 II 输注过程中,总 STAT1 水平没有改变。磷酸化 STAT1 水平在 7 天时达到峰值,比基线增加 1.4 倍(P<.05)。ApoE/STAT1-/- 小鼠在 3、5 和 28 天时分别发生 0%、100%和 100%的动脉瘤。在接受血管紧张素 II 输注>3 天的小鼠中,ApoE/STAT-/- 小鼠的主动脉破裂更频繁(53%比 19%,P<.05)且发生时间更早(4.0+/-0.5 比 9.2+/-0.77 天,P<.05)。在血管紧张素 II 输注期间,两组之间的 SBP 没有差异。28 天时,ApoE/STAT1-/- 小鼠的动脉瘤大于 ApoE-/- 小鼠(2.7+/-0.4 比 1.9+/-0.1mm,P<.05)且更为广泛。在 ApoE-/- 和 ApoE/STAT1-/- 小鼠之间,H&E 和 Movat 染色在基线时未发现主动脉壁结构含量的差异。两组在动脉瘤状态下均表现出同等的紊乱。
磷酸化 STAT1 在动脉瘤变性过程中升高。其缺失与急性主动脉破裂发生率增加和主动脉夹层小鼠模型中更大范围的动脉瘤有关。需要进一步研究以确定这些观察结果是否继发于主动脉壁异常或血管壁基质重塑的改变。